Strength of drug-polymer interactions: Implications on molecular mobility and crystallization in amorphous dispersions
2016-10
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Strength of drug-polymer interactions: Implications on molecular mobility and crystallization in amorphous dispersions
Authors
Published Date
2016-10
Publisher
Type
Thesis or Dissertation
Abstract
Amorphous solid dispersions (ASDs) provide a powerful avenue to potentially enhance the solubility of water-insoluble drugs. However, the physical instability in the amorphous state (i.e. crystallization) is a major impediment to the development ASDs as solid oral dosage forms. By identifying the key factors affecting the stability and the underlying mechanism of stabilization by the polymer, robust solid dispersions can be formulated that are resistant to crystallization. The goal of this thesis work is to (i) gain a mechanistic understanding of the stabilization brought about by drug-polymer interactions, (ii) provide guidelines for rational selection of polymers and (iii) provide simple and rapid methods for predicting crystallization times in ASDs. Overall our objectives were (i) to study the role of the strength of drug-polymer interactions on the molecular mobility and crystallization propensity (both onset time and crystallization rate) of ASDs, (ii) to study the coupling between mobility and crystallization and thereby use molecular mobility as a predictor of crystallization times in ASDs and (iii) provide an accelerated stability screening approach to predict long-term stability of ASDs. In our model systems (ketoconazole ASDs), both an increase in strength of drug-polymer interactions as well as polymer concentration resulted in a disproportionate increase in relaxation times (lowering of the molecular mobility). Stronger drug-polymer interactions translated to longer crystallization onset times and a decrease in the magnitude of crystallization rate constant, indicating enhancement in physical stability. The extent of coupling between relaxation times and crystallization times was moderate (coupling coefficient ~ 0.5) and was unaffected by the strength of drug-polymer interactions. Using molecular mobility as a determinant, a prediction model was developed to estimate crystallization times in ASDs. The predicted and experimental values were in good agreement, indicating the usefulness of the model. Additionally, water sorption was used as an accelerated stability testing approach to rank order ASDs and predict the long-term stability in glassy state. Strong drug-polymer interactions restricted the water uptake in ASDs and provided effective crystallization inhibition in presence of water.
Keywords
Description
University of Minnesota Ph.D. dissertation. October 2016. Major: Pharmaceutics. Advisor: Dr. Raj Suryanarayanan. 1 computer file (PDF); xii, 173 pages.
Related to
Replaces
License
Collections
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Other identifiers
Suggested citation
Mistry, Pinal. (2016). Strength of drug-polymer interactions: Implications on molecular mobility and crystallization in amorphous dispersions. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/201501.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.